Your browser doesn't support javascript.
loading
Sucralose activates an ERK1/2-ribosomal protein S6 signaling axis.
Guerra, Marcy L; Kalwat, Michael A; McGlynn, Kathleen; Cobb, Melanie H.
Afiliação
  • Guerra ML; Department of Pharmacology UT Southwestern Medical Center Dallas TX USA; Present address: Stem Synergy Therapeutics Nashville TN USA.
  • Kalwat MA; Department of Pharmacology UT Southwestern Medical Center Dallas TX USA.
  • McGlynn K; Department of Pharmacology UT Southwestern Medical Center Dallas TX USA.
  • Cobb MH; Department of Pharmacology UT Southwestern Medical Center Dallas TX USA.
FEBS Open Bio ; 7(2): 174-186, 2017 02.
Article em En | MEDLINE | ID: mdl-28174684
The sweetener sucralose can signal through its GPCR receptor to induce insulin secretion from pancreatic ß cells, but the downstream signaling pathways involved are not well-understood. Here we measure responses to sucralose, glucagon-like peptide 1, and amino acids in MIN6 ß cells. Our data suggest a signaling axis, whereby sucralose induces calcium and cAMP, activation of ERK1/2, and site-specific phosphorylation of ribosomal protein S6. Interestingly, sucralose acted independently of mTORC1 or ribosomal S6 kinase (RSK). These results suggest that sweeteners like sucralose can influence ß-cell responses to secretagogues like glucose through metabolic as well as GPCR-mediated pathways. Future investigation of novel sweet taste receptor signaling pathways in ß cells will have implications for diabetes and other emergent fields involving these receptors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Open Bio Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: FEBS Open Bio Ano de publicação: 2017 Tipo de documento: Article